Table 2

 Relative incidence of seizures in risk periods compared with control period (day 90-31 before vaccination and day 31-90 after vaccination) for people with epilepsy and with seizures (n=738) and for people without epilepsy but with seizures (n=121) for all episodes, all doses, and inpatient and outpatient seizures

With epilepsy, with seizures (n=738)Without epilepsy, with seizures (n=121)
No of seizuresRelative incidence (95% CI)No of seizuresRelative incidence (95% CI)
Main model
Risk period:
 Day 1-7411.01 (0.74 to 1.39)50.67 (0.27 to 1.65)
 Day 8-301311.00 (0.83 to 1.21)271.11 (0.73 to 1.70)
Model including buffer period (day 30-1 before vaccination)
Buffer period2001.33 (1.13 to 1.56)281.08 (0.71 to 1.64)
Risk period:
 Day 1-7410.96 (0.69 to 1.33)50.67 (0.27 to 1.63)
 Day 8-301310.95 (0.77 to 1.16)271.10 (0.72 to 1.68)